Brief: Aytu Biopharma Reports Q1 Loss Per Share Of $1.09
15/11/2021 22:15
Nov 15 (Reuters) - Aytu Biopharma Inc AYTU.O :
* Q1 LOSS PER SHARE $1.09
* QUARTERLY REVENUE $21.9 MILLION
Further company coverage: AYTU.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aytu Biopharma
See all newsAytu Biopharma Inc reports results for the quarter ended March 31 - Earnings Summary
Aytu BioPharma Q4 revenue beats analyst estimates on EXXUA sales
Aytu Biopharma Inc expected to post a loss of 32 cents a share - Earnings Preview
Aytu BioPharma Q3 revenue falls amid EXXUA launch
Aytu BioPharma Q2 revenue beats expectations